Physician profile
Luis David Camacho
NPI 1649809005
$2,010.89
in general payments reported to CMS, 2019-2025
11 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.98 · 2021: $41.27 · 2022: $182 · 2023: $37.84 · 2024: $430 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $836.52 | 2025 | Matriderm |
| Axogen | $325.72 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Connector |
| Depuy Synthes Sales INC. | $236.73 | 2022-2025 | Matrixorthognathic |
| Tela Bio, INC. | $142.86 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $139.33 | 2022 | |
| Integra Lifesciences Corporation | $100.00 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kls-Martin L.P. | $82.69 | 2024 | |
| Stryker Corporation | $59.25 | 2020-2023 | Na, Smartlock |
| Astrazeneca Pharmaceuticals LP | $41.27 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $29.68 | 2025 | |
| Baxter Healthcare | $16.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis David Camacho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.